Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Our Psychedelic Compound-Based Clinical-Stage Drug Stocks Portfolio Was Down 16% In August
September 06, 2024
Tickers
ATAI
CMPS
GHRS
MNMD
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!
September 05, 2024
Tickers
ABCL
ABSI
EXAI
RLAY
Tags
Technology
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Patchy But Still Bullish
September 02, 2024
Tickers
AAPL
ABT
AMGN
APO
Tags
Utilities
Options
Capital & Industrial Goods
From
TalkMarkets
Market Thoughts This Labor Day Weekend
September 01, 2024
Tickers
BLOK
FSLR
IBB
LLY
Tags
Technology
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Gilding The Lilly
September 01, 2024
Tickers
LLY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Week In Review: UCB Sells China Drug Portfolio To CBC For $680 Million
August 31, 2024
Tickers
BGNE
BNTX
UCBJY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Biotech And Life Science Sector Update Summer Of 2024
August 29, 2024
Tickers
ABBV
AZN
GILD
LLY
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
Is The S&P 500 On The Verge Of A Breakout?
August 28, 2024
Tickers
GEV
INSG
ONON
ZETA
Tags
Communications
Financial
Consumer Goods
From
TalkMarkets
Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
August 27, 2024
Tickers
ABCL
ABSI
EXAI
RLAY
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Largest Psychedelic Compound -Based Clinical-Stage Drug Stocks Up 6% Last Week
August 24, 2024
Tickers
ATAI
CMPS
GHRS
MNMD
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
Week In Review: Multitude Out-Licenses Tissue Factor ADC To Adcendo In $1 Billion Deal
August 24, 2024
Tickers
ESAIY
IVBXF
MRK
RDY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
August 20, 2024
Tickers
MRK
VKTX
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Biotech Bull Market: 3 Ways To Play It
August 20, 2024
Tickers
ABBV
AZN
GILD
LLY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
ProInvestor Insights - August 2024
August 19, 2024
Tickers
AMGN
APP
CLS
FSLR
Tags
Communications
Financial
Consumer Goods
From
TalkMarkets
Week In Review: Eisai Enters $1.5 Billion Molecular Glues Pact With SEED
August 17, 2024
Tickers
ALC
ASPHF
ESAIY
MKGAF
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Psychedelic Compound-Based Drug Stocks Portfolio: Up 17.5% In July; Down 19% MTD
August 15, 2024
Tickers
ATAI
CMPS
GHRS
MNMD
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
TalkMarkets
Biotech Life Science Trades: Small Caps Are Lagging But Poised For A Q4 Rally
August 13, 2024
Tickers
QQQ
XBI
XLV
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
ETFs Where Are They Now?
August 11, 2024
Tickers
HYG
IBB
IWM
IYT
Tags
Transportation
ETFs
Financial
From
TalkMarkets
Large Cap Biopharma And Healthcare, A Port In A Storm
August 05, 2024
Tickers
ABBV
ABT
IHI
JNJ
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
Divided We Stood, United We Fall
August 04, 2024
Tickers
IBB
IWM
IYT
KRE
Tags
Transportation
ETFs
Pharma/Biotech
From
TalkMarkets
Week In Review: ImmuneOnco Out-Licenses Two Antibodies In $2 Billion Deal
August 03, 2024
Tickers
IDYA
LYPHF
TIL
WUXIF
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
AI-Focused Drug Discovery Stocks Portfolio Up 7% Last Week; Up 19% MTD
July 30, 2024
Tickers
ABCL
ABSI
EXAI
RLAY
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
Healthcare Stocks Are Coming On Strong In July Led By Biotech
July 29, 2024
Tickers
ABT
BMY
IBB
IHF
Tags
Healthcare
ETFs
Market News
From
TalkMarkets
Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal
July 27, 2024
Tickers
ALGS
ARTV
BGNE
BNTX
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
July 22, 2024
Tickers
AZN
GERN
GILD
IBB
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
The Market Requires 7 Pairs Of Eyes!
July 21, 2024
Tickers
BITCOMP
IBB
IWM
IYT
Tags
Technology
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Week In Review: Korea's SK Biopharma Acquires Radiopharmaceutical In $571 Million Deal
July 20, 2024
Tickers
GNNSF
LEGN
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
AI-Powered Drug Discovery Stocks Portfolio Up 14% MTD; Still Down 30% YTD
July 18, 2024
Tickers
ABCL
EXAI
RLAY
SDGR
Tags
Market News
Technology
Pharma/Biotech
From
TalkMarkets
Goldilocks Has Made An Appearance On Wall Street!
July 14, 2024
Tags
Transportation
Services
Utilities
From
TalkMarkets
Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
July 14, 2024
Tickers
ABCL
ABSI
ATAI
CMPS
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.